Abstract:Previous studies have investigated the association between HOXA13 and non-small cell lung cancer. However, the role of HOXA13 expression in the occurrence and progression of lung adenocarcinoma (LUAD) has not yet been investigated. In the present study, HOXA13-related data mining of The Cancer Genome Atlas (TCGA), polymerase chain reaction (PCR) data from our cases and the case information in Oncomine was conducted for validation. The expression data of HOXA13 in lung cancer cell lines were also collected from the Cancer Cell Line Encyclopedia (CCLE) database for further verification. A comprehensive meta-analysis of the expression of HOXA13 was also performed, integrating the data of TCGA, in-house PCR and Oncomine. Genes that were co-expressed with HOXA13 were subsequently identified through cBioPortal and Multi Experiment Matrix (MEM), and the potential role and mechanism of HOXA13 in LUAD was investigated. The expression value of HOXA13 in the LUAD group, which comprised 237 cases, was 3.74±2.694, significantly higher than its expression value in the non-cancerous group (0.92±0.608, P<0.001). The pooled SMD for HOXA13 was 0.346 (95% CI, 0.052-0.640; P=0.068; I2=51.3%; P=0.021), The meta-analysis of diagnostic tests revealed that the area under the summary receiver operating characteristic curve (SROC) was 0.78 (95% CI, 0.75-0.82). The results demonstrated that HOXA13 is highly expressed in LUAD. In addition to the studies on HOXA13 expression in tissues, the expression data of HOXA13 in lung cancer cell lines were also collected from the CCLE database for further verification of these conclusions. Genes that were co-expressed with HOXA13 were identified for pathway analysis. The most enriched Gene Ontology terms in the genes co-expressed with HOXA13 were positive regulation of transcription from RNA polymerase II promoter, signal transduction and positive regulation of GTPase activity in biological process; cytoplasm, integral component of membrane and plasma membrane in cellular component; and significantly involved in protein binding, transcription factor activity, sequence-specific DNA binding and sequence-specific DNA binding in molecular function. Kyoto Encyclopedia of Genes and Genomes analysis revealed that these target genes were clearly involved in Pathways in cancer, Proteoglycans in cancer and cAMP signaling pathway. The hub genes obtained from the four protein-protein interaction networks were associated with HOXA13. The results of the bioinformatics research in the present study revealed that HOXA13 may influence the expression of these hub genes in such a way as to promote the occurrence and development of LUAD. In conclusion, the expression of HOXA13 in patients with LUAD and its potential clinical value were analyzed comprehensively in the present study using data from a variety of sources. Through bioinformatics analysis, evidence that HOXA13 may promote the occurrence and development of LUAD was obtained.

HOXC13 Promotes Proliferation of Lung Adenocarcinoma Via Modulation of CCND1 and CCNE1

Homeobox-A13 Acts As a Functional Prognostic and Diagnostic Biomarker Via Regulating P53 and Wnt Signaling Pathways in Lung Cancer.

The Expression of HOXA13 in Lung Adenocarcinoma and Its Clinical Significance: A Study Based on the Cancer Genome Atlas, Oncomine and Reverse Transcription-Quantitative Polymerase Chain Reaction

HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene

Upregulation of HOXA1 Promotes Tumorigenesis and Development of Non‑small Cell Lung Cancer: A Comprehensive Investigation Based on Reverse Transcription-Quantitative Polymerase Chain Reaction and Bioinformatics Analysis.

HOXC13 Promotes Proliferation of Esophageal Squamous Cell Carcinoma Via Repressing Transcription of CASP3

Upregulation Of Hoxa13 As A Potential Tumorigenesis And Progression Promoter Of Lusc Based On Qrt-Pcr And Bioinformatics

HOXC11 Drives Lung Adenocarcinoma Progression Through Transcriptional Regulation of SPHK1.

HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis

<i>HOXA13</i> promotes colon cancer progression through -catenin-dependent WNT pathway

Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches

HOXA13 promotes colon cancer progression through β-catenin-dependent WNT pathway

Hoxa13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients with Esophageal Squamous Cell Carcinoma

HOXC13 promotes cell proliferation, metastasis and glycolysis in breast cancer by regulating DNMT3A

HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway

HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFβ1 in non-small cell lung cancer

Hoxc10 Promotes Cell Migration, Invasion, And Tumor Growth In Gastric Carcinoma Cells Through Upregulating Proinflammatory Cytokines

A Novel Long Non-Coding RNA LINC00355 Promotes Proliferation of Lung Adenocarcinoma Cells by Down-Regulating Mir-195 and Up-Regulating the Expression of CCNE1.

Overexpression of the transcription factor FOXP3 in lung adenocarcinoma sustains malignant character by promoting G1/S transition gene CCND1

Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis

Identification and Validation of LINC01322 As a Potential Prognostic Biomarker and Oncogene Promoting Tumor Progression in Lung Adenocarcinoma.